Abbott's Earnings Made Easy

By Max Macaluso, Dave Williamson, and Alison Southwick – Oct 16, 2013 at 6:56PM

NYSE: ABT

Abbott Laboratories

Market Cap

$181B

Today's Change

(-0.74%) -$0.78

Current Price

$104.09

Price as of May 17, 2024, 4:00 p.m. ET

What were the takeaways from Abbott's third-quarter results?

This episode of The Motley Fool's Market Checkup dives into the hottest headlines and biggest market movers in the health-care sector and discusses an update on the implementation of the Affordable Care Act.

In this segment from the show, analysts David Williamson and Max Macaluso discuss health-care giant Abbott Laboratories (ABT -0.74%). The company changed dramatically after spinning off its pharmaceutical division into AbbVie (ABBV 1.26%) at the start of 2013. Today, shares of Abbott jumped 6.5% after the company reported its third-quarter results, but what was behind this surge? Could it be the news that Abbott is raising its dividend or its strong earnings? Tune in to find out key takeaways from the report.

Alison Southwick, David Williamson, and Max Macaluso, Ph.D. have no position in any stocks mentioned. The Motley Fool recommends Baxter International. It recommends and owns shares of Johnson & Johnson. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.